Kirr Marbach & CO LLC Horizon Therapeutics Public LTD CO Transaction History

Kirr Marbach & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$62.39 - $113.8 $134,450 - $245,239	-2,155 Reduced 2.25%	93,728 $0
Q3 2022 Oct 26, 2022	SELL	$58.92 - $84.67 $21,564 - $30,989	-366 Reduced 0.38%	95,883 $5.93 Million
Q2 2022 Jul 26, 2022	SELL	$79.4 - $116.36 $6,113 - $8,959	-77 Reduced 0.08%	96,249 $7.68 Million
Q1 2022 May 03, 2022	BUY	$86.42 - $109.81 $96,271 - $122,328	1,114 Added 1.17%	96,326 $10.1 Million
Q4 2021 Jan 21, 2022	BUY	$98.56 - $119.91 $47,210 - $57,436	479 Added 0.51%	95,212 $10.3 Million

Q3 2021 Oct 28, 2021	BUY	$91.91 - $110.37 $198,157 - $237,957	2,156 Added 2.33%	94,733 $10.4 Million
Q2 2021 Jul 19, 2021	BUY	$86.24 - $95.92 $3.67 Million - $4.08 Million	42,577 Added 85.15%	92,577 $8.67 Million
Q1 2021 Apr 19, 2021	BUY	$71.83 - $95.48 $3.59 Million - $4.77 Million	50,000 New	50,000 $4.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Kirr Marbach & CO LLC , based on Form 13F filings with the SEC.

Stay updated on Kirr Marbach & CO LLC with notifications on news.